Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome

Urology

Volumn 63, Issue 1, 2004, Pages 22-26

  Keay, Susan ^a   Zhang, Chen Ou ^b   Chai, Toby ^b   Warren, John ^b   Koch, Kristopher ^b   Grkovic, David ^b   Colville, Heidi ^b   Alexander, Richard ^b  

^a BALTIMORE VA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROLIFERATIVE FACTOR; BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PEPTIDE; THYMIDINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER EPITHELIUM; CHRONIC PROSTATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTERSTITIAL CYSTITIS; MALE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTEIN URINE LEVEL; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 0742272439     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2003.08.024     Document Type: Article

References (33)

1. Schaeffer AJ, Datta NS, Fowler JE, et al: Overview summary statement (Chronic Prostatitis Collaborative Research Network). Urology 60(6 suppl): 1-4, 2002.
2. Nickel JC: Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome. Urology 60(6 suppl): 20-22, 2002.
3. Krieger J.N., Nyberg L. Jr, Nickel J.C. NIH consensus definition and classification of prostatitis. JAMA. 282:1999;236-237.
4. Johansson S.L., Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 143:1990;1118-1124.
5. Hanno P.M., Staskin D.R., Krane R.J., et al. Interstitial Cystitis. 1990;Springer-Verlag, London.
6. Gillenwater J.Y., Wein A.J. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis - National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 140:1988;203-206.
7. Miller J.L., Rothman I., Bavendam T.G., et al. Prostatodynia and interstitial cystitis one and the same? Urology. 45:1995;587-590.
8. Berger R.E., Miller J.E., Rothman I., et al. Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain. J Urol. 159:1998;83-85.
9. Waxman J.A., Sulak P.J., Kuehl T.J. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 160:1998;1663-1667.
10. Keay S, Zhang C-O, Shoenfelt J, et al: Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor and epidermal growth factor as urine markers for interstitial cystitis. Urology 57(6 suppl 1): 9-14, 2001.
11. Keay S., Zhang C.-O., Kagen D.I., et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol. 158:1997;1983-1988.
12. Erickson D.R., Xie S.X., Bhavanandan V.P., et al. A comparison of multiple urine markers for interstitial cystitis. J Urol. 167:2002;2461-2469.
13. Keay S., Kleinberg M., Zhang C.-O., et al. Bladder epithelial cells from interstitial cystitis patients produce an inhibitor of HB-EGF production. J Urol. 64:2000;2112-2118.
14. Miller L.J., Fischer K.A., Goralnick S.J., et al. Nerve growth factor and chronic prostatitis/chronic pelvic pain syndrome. Urology. 59:2002;603-608.
15. Miller L.J., Fischer K.A., Goralnick S.J., et al. Interleukin-10 levels in seminal plasms implications for chronic prostatitis-chronic pelvic pain syndrome . J Urol. 167:2002;753-756.
16. Hochreiter W.W., Nadler R.B., Koch A.E., et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology. 56:2000;1025-1029.
17. 2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol. 166:2001;1738-1741.
18. Ponniah S., Arah I., Alexander R.B. PSA is a candidate self-antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome. Prostate. 44:2000;49-54.
19. Neal D.E. Jr, Clejan S., Sarma D., et al. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate. 20:1992;105-111.
20. Schatteman P.H., Hoekx L., Wyndaele J.J., et al. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis correlation with total serum PSA and PSA density . Eur Urol. 37:2000;404-412.
21. Nadler R.B., Koch A.E., Calhoun E.A., et al. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 164:2000;214-218.
22. John H., Barghorn A., Funke G., et al. Noninflammatory chronic pelvic pain syndrome immunological study in blood, ejaculate and prostate tissue . Eur Urol. 39:2001;72-78.
23. Alexander R.B., Ponniah S., Hasday J., et al. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 52:1998;744-749.
24. Peters K.M., Diokno A.C., Steinert B.W. Preliminary study on urinary cytokine levels in interstitial cystitis does intravesical bacilli Calmette-Guérin treat interstitial cystitis by altering the immune profile in the bladder? Urology. 54:1999;450-453.
25. Okragly A.J., Niles A.L., Saban R., et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol. 161:1999;438-441.
26. Lynes W.L., Flynn S.D., Shortliffe L.D. Mast cell involvement in interstitial cystitis. J Urol. 138:1987;746-752.
27. Parsons C.L., Albo M. Intravesical potassium sensitivity in patients with prostatitis. J Urol. 168:2002;1054-1057.
28. Parsons C.L., Stein P.C., Bidair M., et al. Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn. 13:1994;515-520.
29. Parsons C.L., Dell J., Stanford E.J., et al. The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol. 187:2002;1395-1400.
30. Chai T.C., Zhang C.-O., Shoenfelt J.L., et al. Bladder stretch alters urinary levels of HB-EGF and antiproliferative factor in interstitial cystitis patients. J Urol. 163:2000;1440-1444.
31. Chai T.C., Zhang C.-O., Warren J.W., et al. Percutaneous sacral 3rd nerve root (S3) neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in interstitial cystitis patients. Urology. 55:2000;643-646.
32. Forrest J.B., Vo Q. Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology. 57:2001;26-29.
33. Koziol J.A., Clark D.C., Gittes R.F., et al. The natural history of interstitial cystitis a survey of 374 patients . J Urol. 149:1993;465-469.